Dynamic Polymer Nanoparticle Hydrogel for Sustained Ocular Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current long-acting delivery (LAD) technologies for ocular therapeutics face challenges such as burst release, mismatched drug release and depot degradation timescales, complex manufacturing, and limited compatibility with various payloads, which affect patient compliance and treatment efficacy.
Innovation Solution
The development of dynamic polymer nanoparticle (PNP) hydrogels that exhibit shear-thinning, self-healing, and viscoelastic properties, allowing for controlled and sustained release of ocular therapeutics like bimatoprost through intravitreal injection, forming a localized depot in the vitreous humor.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional long-acting delivery technologies are used, then sustained drug exposure is achieved, but burst release occurs and treatment efficacy is compromised
Solution Approach 1:
The patent modifies the physical and chemical parameters of the delivery system by using polymer nanoparticle hydrogels with controlled molecular weight, composition, and crosslinking density. These parameter changes enable the system to achieve sustained drug release without burst release, resolving the contradiction between duration of action and treatment efficacy.
Solution Approach 2:
The patent employs composite material structures combining polymer nanoparticles with hydrogel matrices, creating a multi-component delivery system. This composite approach allows for controlled drug release kinetics while maintaining structural integrity, preventing burst release and ensuring sustained therapeutic effect.
2Duration of action of moving object
If existing LAD technologies are used, then sustained release is achieved, but the release and depot degradation timescales are mismatched
Solution Approach 1:
The patent precisely controls the degradation parameters of the polymer nanoparticles by selecting specific polymer types, molecular weights, and crosslinking densities. This enables the depot to degrade at the same rate as the drug releases, achieving synchronized timescales between release and degradation, eliminating the mismatch found in conventional systems.
3Reliability
If complex manufacturing processes are used, then delivery system performance is improved, but manufacturing complexity increases
Solution Approach 1:
The patent segments the manufacturing process into modular steps: synthesis of polymer nanoparticles, formation of hydrogel matrix, and incorporation of therapeutic agents. This segmentation allows each component to be manufactured and characterized independently, simplifying the overall manufacturing process while maintaining delivery system performance.
4Productivity
If current delivery systems are used, then specific payloads are delivered, but compatibility with various drug modalities is limited
Solution Approach 1:
The patent designs a universal delivery platform using polymer nanoparticle hydrogels that can accommodate multiple drug modalities including small molecules, peptides, and proteins. The system's tunable properties allow it to be adapted for different payloads, achieving both efficient delivery and broad compatibility without requiring separate systems for each drug type.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PNP hydrogel system provides a prolonged and controlled release of ocular therapeutics, potentially extending the treatment period to several months from a single administration, while maintaining biocompatibility and avoiding adverse immune responses.
Implementation Method 1
dynamic polymer nanoparticle (PNP) hydrogels that exhibit shear-thinning, self-healing, and viscoelastic properties
Implementation Method 2
dynamic polymer nanoparticle (PNP) hydrogels that exhibit shear-thinning, self-healing, and viscoelastic properties
Implementation Method 3
dynamic polymer nanoparticle (PNP) hydrogels that exhibit shear-thinning, self-healing, and viscoelastic properties
Implementation Method 4
The PNP hydrogel system provides a prolonged and controlled release of ocular therapeutics
Data Source
AI summary
Compositions for treating ocular disease are disclosed herein. In some embodiments, the composition comprises a dynamic hydrogel comprising a polymer and a plurality of nanoparticles, wherein the polymer is non-covalently crosslinked with the plurality of nanoparticles. The dynamic hydrogel can also comprise an ocular therapeutic encapsulated by the dynamic hydrogel.